Today: 4 July 2026
Browse Category

Stock Market 8 January 2026 - 9 January 2026

Opendoor stock pops after Trump targets big homebuyers as CEO insists firm “doesn’t hold the homes”

Opendoor stock pops after Trump targets big homebuyers as CEO insists firm “doesn’t hold the homes”

Opendoor Technologies shares rose Thursday after CEO Kaz Nejatian dismissed worries from investors over President Donald Trump’s plan to crack down on large institutional homebuyers. “We’re not institutional investors … We don’t hold the homes!” Nejatian insisted. https://www.tradingview.com/news/stockstory:ea2657819094b:0-opendoor-open-shares-skyrocket-what-you-need-to-know/ The rebound is significant because Trump’s housing message has already started shifting investments within the sector, even though Washington has provided few details. Trump said he was “immediately taking steps” to stop large institutions from buying more single-family homes and called on Congress to make the ban official, adding: “People live in homes, not corporations.” https://www.cbsnews.com/news/trump-ban-institutional-investors-single-family-homes/
Eli Lilly stock slips on Zepbound-Taltz trial data as Ventyx deal, pricing debate loom

Eli Lilly stock slips on Zepbound-Taltz trial data as Ventyx deal, pricing debate loom

New York, Jan 8, 2026, 18:23 EST — After-hours Shares of Eli Lilly fell 2.1% on Thursday, trading between $1,070.16 and $1,133.06, and were last at $1,085.19 in after-hours activity after the drugmaker reported late-stage data on a Zepbound-Taltz combination in psoriatic arthritis. Lilly said 31.7% of patients on the combo met a dual goal — at least 50% lower disease activity and at least 10% weight loss after 36 weeks — compared with 0.8% on Taltz alone. Senior vice president Mark Genovese said the results support an “integrated treatment approach” for the inflammatory joint disease, which affects up to a third of people with psoriasis; nausea, diarrhea and constipation were among the most common side effects, Lilly said. Reuters
Rocket Lab stock slips after CFO’s $103 million share sale filing; what investors watch next

Rocket Lab stock slips after CFO’s $103 million share sale filing; what investors watch next

New York, January 8, 2026, 18:29 EST — After-hours Rocket Lab Corp shares dipped in after-hours trading on Thursday after a regulatory filing showed Chief Financial Officer Adam C. Spice sold about $103 million of stock under a Rule 10b5-1 plan, which sets trades in advance. The stock closed down 1.2% at $83.08 and slipped to $82.98 after the bell, leaving the space company valued at about $44.4 billion. Spice sold 1,365,665 shares at weighted-average prices ranging from $71.49 to $78.24 and exercised options to buy 731,330 shares, the filing showed. SEC+1
Applied Digital (APLD) stock jumps after earnings beat as AI data-center lease talks stay in focus

Applied Digital (APLD) stock jumps after earnings beat as AI data-center lease talks stay in focus

New York, January 8, 2026, 18:22 EST — After-hours Applied Digital Corp shares rose about 8% in after-hours trading on Thursday after a volatile session, as investors digested the company’s quarterly update and its push to lock in long-term customers for AI-focused data centers. The stock was last up 8.0% at $31.94 after ranging from $30.61 to $35.44.
Bloom Energy stock jumps after AEP discloses $2.65 billion fuel-cell deal in Wyoming

Bloom Energy stock jumps after AEP discloses $2.65 billion fuel-cell deal in Wyoming

NEW YORK, January 8, 2026, 18:19 — After-hours Bloom Energy shares jumped in after-hours trading on Thursday after American Electric Power disclosed a roughly $2.65 billion deal to buy the fuel-cell maker’s equipment for a new power generation facility in Wyoming. The stock was last up 12.8% at $121.84, after ranging from $106.70 to $128.00 during the session. Reuters
Meta Platforms stock dips as China opens probe into Manus AI deal

Meta Platforms stock dips as China opens probe into Manus AI deal

New York, Jan 8, 2026, 17:54 EST — After-hours Meta Platforms, Inc. shares slipped on Thursday, closing just a bit lower before holding steady in after-hours trading. This came after China said it would review the Facebook parent’s acquisition of AI startup Manus. The stock wrapped up the day down 0.4% at $646.06, bouncing between $635.79 and $647.03 during the session. China’s commerce ministry announced it would team up with other agencies to carry out the review. Spokesman He Yadong made it clear that deals involving foreign investment, technology exports, and overseas data transfers have to comply with Chinese law. Reuters
Sandisk stock slips in late trade after AI-storage rally cools — what investors watch next

Sandisk stock slips in late trade after AI-storage rally cools — what investors watch next

New York, January 8, 2026, 17:51 — After-hours Sandisk shares were down 5.3% at $334.54 in late trading on Thursday, after closing the regular session sharply lower and erasing part of this week’s CES-fueled jump. The stock swung between $311.07 and $363.74 on the day after finishing Wednesday at $353.40.
Nvidia stock slips after report on China H200 payments as jobs data and earnings loom

Nvidia stock slips after report on China H200 payments as jobs data and earnings loom

New York, January 8, 2026, 5:19 PM EST — After-hours Nvidia shares fell on Thursday after Reuters reported the chipmaker is demanding full upfront payment from Chinese customers for its H200 data-center chips, used to train and run AI models. The stock slipped 2.1% to $185.04 in late trading, after hitting $190.28 earlier and falling as low as $183.77. Chinese firms have placed orders for more than 2 million H200s priced around $27,000 each, far above Nvidia’s inventory of about 700,000 units, as local alternatives still lag for large-scale AI training. Reuters
Bitcoin price hovers near $91,000 as ETF money turns; Strategy stock ticks up after MSCI call

Bitcoin price hovers near $91,000 as ETF money turns; Strategy stock ticks up after MSCI call

NEW YORK, Jan 8, 2026, 17:13 EST — After-hours Bitcoin was last up 0.2% at $91,142 on Thursday, after sliding as low as $89,312 earlier in the session, and U.S.-listed crypto stocks finished mixed in extended trading. Strategy was up 3.2%, while Coinbase slipped 0.1%; miners Marathon Digital and Riot Platforms rose 3.7% and fell 1.0%, respectively.
MoonLake stock jumps after FDA feedback clears path for sonelokimab filing without new HS trials

MoonLake stock jumps after FDA feedback clears path for sonelokimab filing without new HS trials

New York, Jan 8, 2026, 17:06 EST — After-hours MoonLake Immunotherapeutics shares jumped 27% to $14.34 on Thursday after the biotech said U.S. regulators supported a route to file its hidradenitis suppurativa treatment without doing more trials for the skin disease. The stock churned between $11.20 and $17.28, and roughly 24 million shares traded.

Stock Market Today

  • CG Power Results Match Views, 2027 Outlook Unchanged as Shares Drop
    July 3, 2026, 10:38 PM EDT. CG Power and Industrial Solutions Limited's full-year revenue came in at ₹124 billion, with earnings per share of ₹7.71, matching analyst estimates. The stock slipped 5.3% after the numbers landed. Analysts at 19 brokerages are holding their 2027 revenue call at ₹156.6 billion, or 26% higher, and EPS at ₹10.30, up 35%. The consensus target price stays at ₹892, with targets spread from ₹502 to ₹1,100, showing a wide range of calls on where the shares go next. CG Power is projected to grow revenue at 26% annually through 2027, ahead of sector growth of 18%, after running at 22% historically. The results were steady, with no changes to analyst sentiment or forecasts.
Go toTop